vs

Side-by-side financial comparison of CORVEL CORP (CRVL) and UNIVERSAL TECHNICAL INSTITUTE INC (UTI). Click either name above to swap in a different company.

CORVEL CORP is the larger business by last-quarter revenue ($235.6M vs $221.4M, roughly 1.1× UNIVERSAL TECHNICAL INSTITUTE INC). CORVEL CORP runs the higher net margin — 10.3% vs 0.2%, a 10.1% gap on every dollar of revenue. On growth, UNIVERSAL TECHNICAL INSTITUTE INC posted the faster year-over-year revenue change (6.7% vs 3.4%). Over the past eight quarters, UNIVERSAL TECHNICAL INSTITUTE INC's revenue compounded faster (11.7% CAGR vs 6.6%).

Corvel Corp is a U.S.-headquartered provider of integrated workers’ compensation, healthcare management, and risk mitigation solutions. It serves insurance carriers, self-insured employers, and public sector clients, delivering services to control healthcare costs, improve care outcomes, and optimize administrative operations.

Universal Technical Institute, Inc. (UTI) is a private for-profit system of technical colleges in the United States. It was established in 1965 by Robert Sweet.

CRVL vs UTI — Head-to-Head

Bigger by revenue
CRVL
CRVL
1.1× larger
CRVL
$235.6M
$221.4M
UTI
Growing faster (revenue YoY)
UTI
UTI
+3.4% gap
UTI
6.7%
3.4%
CRVL
Higher net margin
CRVL
CRVL
10.1% more per $
CRVL
10.3%
0.2%
UTI
Faster 2-yr revenue CAGR
UTI
UTI
Annualised
UTI
11.7%
6.6%
CRVL

Income Statement — Q4 FY2025 vs Q2 FY2026

Metric
CRVL
CRVL
UTI
UTI
Revenue
$235.6M
$221.4M
Net Profit
$24.2M
$433.0K
Gross Margin
23.3%
Operating Margin
13.7%
0.2%
Net Margin
10.3%
0.2%
Revenue YoY
3.4%
6.7%
Net Profit YoY
1.7%
-60.5%
EPS (diluted)
$0.47
$0.01

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CRVL
CRVL
UTI
UTI
Q1 26
$221.4M
Q4 25
$235.6M
$220.8M
Q3 25
$239.6M
$222.4M
Q2 25
$234.7M
$204.3M
Q1 25
$231.5M
$207.4M
Q4 24
$228.0M
$201.4M
Q3 24
$224.4M
$196.4M
Q2 24
$211.7M
$177.5M
Net Profit
CRVL
CRVL
UTI
UTI
Q1 26
$433.0K
Q4 25
$24.2M
$12.8M
Q3 25
$27.9M
$18.8M
Q2 25
$27.2M
$10.7M
Q1 25
$26.4M
$11.4M
Q4 24
$23.8M
$22.2M
Q3 24
$23.4M
$18.8M
Q2 24
$21.6M
$5.0M
Gross Margin
CRVL
CRVL
UTI
UTI
Q1 26
Q4 25
23.3%
Q3 25
24.3%
Q2 25
24.2%
Q1 25
25.0%
Q4 24
23.2%
Q3 24
22.6%
Q2 24
22.7%
Operating Margin
CRVL
CRVL
UTI
UTI
Q1 26
0.2%
Q4 25
13.7%
7.1%
Q3 25
15.0%
11.2%
Q2 25
15.0%
6.9%
Q1 25
14.4%
8.1%
Q4 24
13.5%
13.6%
Q3 24
12.8%
13.3%
Q2 24
13.2%
4.2%
Net Margin
CRVL
CRVL
UTI
UTI
Q1 26
0.2%
Q4 25
10.3%
5.8%
Q3 25
11.6%
8.4%
Q2 25
11.6%
5.2%
Q1 25
11.4%
5.5%
Q4 24
10.4%
11.0%
Q3 24
10.4%
9.6%
Q2 24
10.2%
2.8%
EPS (diluted)
CRVL
CRVL
UTI
UTI
Q1 26
$0.01
Q4 25
$0.47
$0.23
Q3 25
$0.54
$0.33
Q2 25
$0.52
$0.19
Q1 25
$-1.23
$0.21
Q4 24
$0.46
$0.40
Q3 24
$1.35
$0.35
Q2 24
$1.25
$0.09

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CRVL
CRVL
UTI
UTI
Cash + ST InvestmentsLiquidity on hand
$230.0M
$162.0M
Total DebtLower is stronger
$127.8M
Stockholders' EquityBook value
$375.7M
$339.9M
Total Assets
$644.8M
$852.2M
Debt / EquityLower = less leverage
0.38×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CRVL
CRVL
UTI
UTI
Q1 26
$162.0M
Q4 25
$230.0M
$162.8M
Q3 25
$207.5M
$169.1M
Q2 25
$202.0M
$70.7M
Q1 25
$170.6M
$96.0M
Q4 24
$162.9M
$172.0M
Q3 24
$138.3M
$161.9M
Q2 24
$131.9M
$115.5M
Total Debt
CRVL
CRVL
UTI
UTI
Q1 26
$127.8M
Q4 25
$101.4M
Q3 25
$87.1M
Q2 25
$73.8M
Q1 25
$94.4M
Q4 24
$120.1M
Q3 24
$125.7M
Q2 24
$137.3M
Stockholders' Equity
CRVL
CRVL
UTI
UTI
Q1 26
$339.9M
Q4 25
$375.7M
$335.9M
Q3 25
$362.8M
$328.1M
Q2 25
$342.5M
$306.8M
Q1 25
$322.0M
$293.9M
Q4 24
$300.9M
$280.0M
Q3 24
$282.8M
$260.2M
Q2 24
$263.9M
$239.4M
Total Assets
CRVL
CRVL
UTI
UTI
Q1 26
$852.2M
Q4 25
$644.8M
$834.0M
Q3 25
$611.7M
$826.1M
Q2 25
$597.4M
$740.8M
Q1 25
$546.0M
$720.4M
Q4 24
$538.8M
$753.8M
Q3 24
$518.6M
$744.6M
Q2 24
$486.2M
$706.0M
Debt / Equity
CRVL
CRVL
UTI
UTI
Q1 26
0.38×
Q4 25
0.30×
Q3 25
0.27×
Q2 25
0.24×
Q1 25
0.32×
Q4 24
0.43×
Q3 24
0.48×
Q2 24
0.57×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CRVL
CRVL
UTI
UTI
Operating Cash FlowLast quarter
$46.1M
$7.1M
Free Cash FlowOCF − Capex
$35.2M
FCF MarginFCF / Revenue
14.9%
Capex IntensityCapex / Revenue
4.7%
Cash ConversionOCF / Net Profit
1.91×
16.33×
TTM Free Cash FlowTrailing 4 quarters
$104.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CRVL
CRVL
UTI
UTI
Q1 26
$7.1M
Q4 25
$46.1M
$3.1M
Q3 25
$25.0M
$57.1M
Q2 25
$55.0M
$18.1M
Q1 25
$22.9M
$-789.0K
Q4 24
$41.6M
$23.0M
Q3 24
$22.3M
$67.5M
Q2 24
$40.4M
$10.0M
Free Cash Flow
CRVL
CRVL
UTI
UTI
Q1 26
Q4 25
$35.2M
$-19.2M
Q3 25
$15.3M
$40.6M
Q2 25
$39.5M
$6.8M
Q1 25
$14.3M
$-11.7M
Q4 24
$32.1M
$19.6M
Q3 24
$12.4M
$60.0M
Q2 24
$32.8M
$3.0M
FCF Margin
CRVL
CRVL
UTI
UTI
Q1 26
Q4 25
14.9%
-8.7%
Q3 25
6.4%
18.3%
Q2 25
16.8%
3.4%
Q1 25
6.2%
-5.7%
Q4 24
14.1%
9.7%
Q3 24
5.5%
30.6%
Q2 24
15.5%
1.7%
Capex Intensity
CRVL
CRVL
UTI
UTI
Q1 26
Q4 25
4.7%
10.1%
Q3 25
4.1%
7.4%
Q2 25
6.6%
5.5%
Q1 25
3.7%
5.3%
Q4 24
4.2%
1.7%
Q3 24
4.4%
3.8%
Q2 24
3.6%
4.0%
Cash Conversion
CRVL
CRVL
UTI
UTI
Q1 26
16.33×
Q4 25
1.91×
0.24×
Q3 25
0.90×
3.04×
Q2 25
2.02×
1.69×
Q1 25
0.87×
-0.07×
Q4 24
1.75×
1.04×
Q3 24
0.95×
3.58×
Q2 24
1.87×
2.01×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CRVL
CRVL

Patient Management Services$146.1M62%
Network Solutions Services$89.6M38%

UTI
UTI

Segment breakdown not available.

Related Comparisons